Characteristics of pancreatic carcinoma in the elderly
Tóm tắt
Lymphogenous as well as hematogenous metastases were significantly less frequent in the elderly group of patients, although local invasion was comparable. Survival was comparable between both groups although palliative therapy alone was significantly more frequent in the elderly. The relative and absolute numbers of elderly patients continue to increase, as does the incidence of pancreatic carcinoma. To determine the optimal therapy for elderly patients with pancreatic carcinoma, we examined their clinicopathological features. The clinical and histopathological features of pancreatic carcinoma in patients 70 yr of age or older (n=89) were compared with those in patients aged 69 yr or less (n=184). A total of 273 patients showed histologically tubular adenocarcinomas and their major variants. The male: female ratio peaked at 1∶0.3 in patients under 49 yr old but gradually decreased to 1∶1.2 in those aged over 80 yr. There were no significant differences between the two groups in the resectability, prognosis, location, or histology of the tumor. Hematogenous and lymphogeneous metastases were detected at autopsy in 68 and 61% of patients older than 70, and in 82 and 80% of the younger group.
Tài liệu tham khảo
Kairaluoma MI, Kiviniemi H, Stahlberg M. Pancreatic resection for carcinoma of the pancreas and the periampullary region in patients over 70 years of age.Br J Surg 1987;74:116–118.
Spencer MP, Sarr MG, Nagorney DM. Radical pancreatectomy for pancreatic cancer in the elderly.Ann Surg 1990;202:140–143.
Hatori T. A clinicopathological study of ductal adenocarcinoma of the head of the pancreas in aged patients 70 years and older.J Jpn Panc Soc 1993;8:506–515.
Japan Pancreas Society. General rules for cancer of the pancreas, 3rd ed., Kanehara, Tokyo, 1986.
Solcia E, Capella C, Kloppel G. Classification of pancreatic tumors, inAtlas of Tumor Pathology, Tumors of the Pancreas, AFIP, Washington 1997; pp. 25–28.
Kamisawa T, Isawa T, Koike M, Tsuruta K, Okamoto A. Hematogenous metastases of pancreatic ductal carcinoma.Pancreas 1995;11:345–349.
Greenway BA. Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?Br J Surg 1987;74:441,442.
Greenway BA, Iqbal MJ, Johnson PJ, Williams R. Oestrogen receptor proteins in malignant and fetal pancreas.Br Med J 1981;283:751–753.
Corbishley TP, Iqbal MJ, Johnson PJ, Williams R. Progesterone receptors in malignant and foetal pancreatic tissue.IRCS Med Sci 1984;12:575,576.
Corbishley TP, Iqbal MJ, Wilkinson ML, Williams R. Androgen receptor in human normal and malignant pancreatic tissue and cell lines.Cancer 1986;57:19,992–19,995.
Iqbal MJ, Greenway BA, Wilkinson ML, Johnson PJ, Williams R. Sex-steroid enzymes, aromatase and α-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue.Clin Sci 1983;65:71–75.
Lhoste EF, Roebuck BD, Brinck-Johnsen T, Longnecker DS. Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats.Carcinogenesis 1987;8:699–703.
Benz C, Hollander C, Miller B. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.Cancer Res 1986; 46:2276–2281.
Lin RS, Kessler II. A multifactorial model for pancreatic cancer in man. Epidemiologic evidence.JAMA 1981; 245:147–152.
Bourhis J, Lacaine F, Augusti M, Huguier M. Protective effect of oestrogen in pancreatic cancer.Lancet 1987; ii:977.
Mikal S, Campbell ALA. Carcinoma of the pancreas. Diagnostic and operative criteria based on the hundred consecutive autopsies.Surgery 1950;28:963–969.
Kloppel G, Sosnowski J, Eichfuss H-P, Ruckert K, Klapdor R. Aktuelle Aspekte des Pankreaskarzinoms. Klinische Therapie.Deutsche Medizinische Wochenschrift 1979; 104:1801–1805.